These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31322555)

  • 1. Nanobodies: The "Magic Bullets" in therapeutics, drug delivery and diagnostics.
    Mir MA; Mehraj U; Sheikh BA; Hamdani SS
    Hum Antibodies; 2020; 28(1):29-51. PubMed ID: 31322555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobodies as novel agents for disease diagnosis and therapy.
    Siontorou CG
    Int J Nanomedicine; 2013; 8():4215-27. PubMed ID: 24204148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
    Bannas P; Hambach J; Koch-Nolte F
    Front Immunol; 2017; 8():1603. PubMed ID: 29213270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
    Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
    Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of Nanobodies.
    Muyldermans S
    Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobodies derived from Camelids represent versatile biomolecules for biomedical applications.
    Yu X; Xu Q; Wu Y; Jiang H; Wei W; Zulipikaer A; Guo Y; Jirimutu ; Chen J
    Biomater Sci; 2020 Jul; 8(13):3559-3573. PubMed ID: 32490444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
    Jin BK; Odongo S; Radwanska M; Magez S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Domain Antibodies or Nanobodies: A Class of Next-Generation Antibodies.
    Khodabakhsh F; Behdani M; Rami A; Kazemi-Lomedasht F
    Int Rev Immunol; 2018; 37(6):316-322. PubMed ID: 30741045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, Screening, and Validation of Camelid-Derived Nanobodies for Neuroscience Research.
    Gavira-O'Neill CE; Dong JX; Trimmer JS
    Curr Protoc Neurosci; 2020 Dec; 94(1):e107. PubMed ID: 33185319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanobodies and their potential applications.
    Hassanzadeh-Ghassabeh G; Devoogdt N; De Pauw P; Vincke C; Muyldermans S
    Nanomedicine (Lond); 2013 Jun; 8(6):1013-26. PubMed ID: 23730699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics.
    Mujić-Delić A; de Wit RH; Verkaar F; Smit MJ
    Trends Pharmacol Sci; 2014 May; 35(5):247-55. PubMed ID: 24690241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
    Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D
    Biochem Biophys Res Commun; 2014 Mar; 446(1):132-6. PubMed ID: 24569074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment.
    Wang J; Kang G; Yuan H; Cao X; Huang H; de Marco A
    Front Immunol; 2021; 12():838082. PubMed ID: 35116045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.
    Wesolowski J; Alzogaray V; Reyelt J; Unger M; Juarez K; Urrutia M; Cauerhff A; Danquah W; Rissiek B; Scheuplein F; Schwarz N; Adriouch S; Boyer O; Seman M; Licea A; Serreze DV; Goldbaum FA; Haag F; Koch-Nolte F
    Med Microbiol Immunol; 2009 Aug; 198(3):157-74. PubMed ID: 19529959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INDI-integrated nanobody database for immunoinformatics.
    Deszyński P; Młokosiewicz J; Volanakis A; Jaszczyszyn I; Castellana N; Bonissone S; Ganesan R; Krawczyk K
    Nucleic Acids Res; 2022 Jan; 50(D1):D1273-D1281. PubMed ID: 34747487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanobodies as molecular imaging probes.
    Barakat S; Berksöz M; Zahedimaram P; Piepoli S; Erman B
    Free Radic Biol Med; 2022 Mar; 182():260-275. PubMed ID: 35240292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of camel single-domain antibodies for the diagnosis and treatment of zoonotic diseases.
    Lafaye P; Li T
    Comp Immunol Microbiol Infect Dis; 2018 Oct; 60():17-22. PubMed ID: 30396425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting tumors with nanobodies for cancer imaging and therapy.
    Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM
    J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of nanobodies against epithelial cell adhesion molecule as novel theranostic agents for cancer therapy.
    Roshan R; Naderi S; Behdani M; Cohan RA; Ghaderi H; Shokrgozar MA; Golkar M; Kazemi-Lomedasht F
    Mol Immunol; 2021 Jan; 129():70-77. PubMed ID: 33183767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.